179 related articles for article (PubMed ID: 30619696)
1. Prevalence of dynapenic obesity and sarcopenic obesity and their associations with cardiovascular disease risk factors in peritoneal dialysis patients.
Tabibi H; As'habi A; Najafi I; Hedayati M
Kidney Res Clin Pract; 2018 Dec; 37(4):404-413. PubMed ID: 30619696
[TBL] [Abstract][Full Text] [Related]
2. Worsening Disability and Hospitalization Risk in Sarcopenic Obese and Dynapenic Abdominal Obese: A 5.5 Years Follow-Up Study in Elderly Men and Women.
Rossi AP; Urbani S; Fantin F; Nori N; Brandimarte P; Martini A; Zoico E; Mazzali G; Babbanini A; Muollo V; Zamboni M
Front Endocrinol (Lausanne); 2020; 11():314. PubMed ID: 32695067
[No Abstract] [Full Text] [Related]
3. Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19.
Pérez-Campos Mayoral L; Matias-Cervantes CA; Pérez-Campos E; Romero Díaz C; Laguna Barrios LÁ; Pina Canseco MDS; Martínez Cruz M; Pérez-Campos Mayoral E; Solórzano Mata CJ; Rodal Canales FJ; Martínez Ruíz H; Hernández-Huerta MT
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955411
[TBL] [Abstract][Full Text] [Related]
4. Associations of Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures Over 5-10 Years in Community-Dwelling Older Adults.
Scott D; Chandrasekara SD; Laslett LL; Cicuttini F; Ebeling PR; Jones G
Calcif Tissue Int; 2016 Jul; 99(1):30-42. PubMed ID: 26939775
[TBL] [Abstract][Full Text] [Related]
5. Associations of Body Composition, Muscle Function, and Physical Activity with Mortality in Peritoneal Dialysis Patients.
Tabibi H; As'habi A; Najafi I; Hedayati M
Iran J Kidney Dis; 2020 May; 14(3):224-230. PubMed ID: 32361700
[TBL] [Abstract][Full Text] [Related]
6. Obesity phenotypes are, in part, associated with physical activity in diabetic hemodialysis patients.
de Oliveira Matos B; da Costa Rosa CS; Ribeiro HS; Marcos NM; Losilla MPR; Monteiro HL; Gimenes C
Int Urol Nephrol; 2022 Jul; 54(7):1751-1759. PubMed ID: 34816362
[TBL] [Abstract][Full Text] [Related]
7. Association between sarcopenic obesity and mortality in patients on peritoneal dialysis: a prospective cohort study.
Shen Y; Su X; Yu Z; Yan H; Ma D; Xu Y; Yuan J; Ni Z; Gu L; Fang W
Front Med (Lausanne); 2024; 11():1342344. PubMed ID: 38449887
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Protein-Energy Wasting and Its Association With Cardiovascular Disease Risk Factors in Iranian Peritoneal Dialysis Patients.
As'habi A; Najafi I; Tabibi H; Hedayati M
Iran J Kidney Dis; 2019 Jan; 13(1):48-55. PubMed ID: 30851719
[TBL] [Abstract][Full Text] [Related]
9. Positive impact of obesity on the prognosis of liver cirrhosis.
Endo K; Kakisaka K; Abe T; Yusa K; Nakaya I; Watanabe T; Suzuki A; Yoshida Y; Oikawa T; Miyasaka A; Kuroda H; Matsumoto T
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38700075
[TBL] [Abstract][Full Text] [Related]
10. Dynapenic Abdominal Obesity as a Predictor of Worsening Disability, Hospitalization, and Mortality in Older Adults: Results From the InCHIANTI Study.
Rossi AP; Bianchi L; Volpato S; Bandinelli S; Guralnik J; Zamboni M; Ferrucci L
J Gerontol A Biol Sci Med Sci; 2017 Aug; 72(8):1098-1104. PubMed ID: 28329134
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Sarcopenia and Dynapenia and Their Determinants in Iranian Peritoneal Dialysis Patients.
As'habi A; Najafi I; Tabibi H; Hedayati M
Iran J Kidney Dis; 2018 Jan; 12(1):53-60. PubMed ID: 29421778
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
13. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
14. Dynapenic-obesity and physical function in older adults.
Bouchard DR; Janssen I
J Gerontol A Biol Sci Med Sci; 2010 Jan; 65(1):71-7. PubMed ID: 19887536
[TBL] [Abstract][Full Text] [Related]
15. Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: A 10-year prospective study.
Rossi AP; Fantin F; Caliari C; Zoico E; Mazzali G; Zanardo M; Bertassello P; Zanandrea V; Micciolo R; Zamboni M
Clin Nutr; 2016 Feb; 35(1):199-204. PubMed ID: 25736030
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults.
Scott D; Sanders KM; Aitken D; Hayes A; Ebeling PR; Jones G
Obesity (Silver Spring); 2014 Jun; 22(6):1568-74. PubMed ID: 24585708
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenic obesity and physical performance in middle aged women: a cross-sectional study in Northeast Brazil.
Moreira MA; Zunzunegui MV; Vafaei A; da Câmara SM; Oliveira TS; Maciel ÁC
BMC Public Health; 2016 Jan; 16():43. PubMed ID: 26775160
[TBL] [Abstract][Full Text] [Related]
18. Dynapenic obesity and lower extremity function in elderly adults.
Yang M; Jiang J; Hao Q; Luo L; Dong B
J Am Med Dir Assoc; 2015 Jan; 16(1):31-6. PubMed ID: 25227695
[TBL] [Abstract][Full Text] [Related]
19. Relationship between dynapenia and cardiorespiratory functions in healthy postmenopausal women: novel clinical criteria.
Barbat-Artigas S; Dupontgand S; Fex A; Karelis AD; Aubertin-Leheudre M
Menopause; 2011 Apr; 18(4):400-5. PubMed ID: 21107297
[TBL] [Abstract][Full Text] [Related]
20. Muscle-to-fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity.
Yu PC; Hsu CC; Lee WJ; Liang CK; Chou MY; Lin MH; Hsiao FY; Peng LN; Chen LK
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):368-376. PubMed ID: 34866342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
